Edit
PlateletBio
http://www.plateletbiogenesis.com/Last activity: 09.09.2019
Active - Reference to PlateletBio
PlateletBio is the only allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a completely new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a superior cell therapy empowered to tackle previously unmet medical challenges.
Location: United States, Massachusetts, Watertown
Employees: 51-200
Total raised: $36M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | MassChalle... | masschalle... |
| - | eCoast Ang... | ecoastange... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.09.2019 | Series A | $26M | - |
| 09.06.2017 | Series A | $10M | - |
Mentions in press and media 10
| Date | Title | Description |
| 09.09.2019 | Platelet BioGenesis Raises $26M in Series A-1 Financing | Platelet BioGenesis, Inc. (PBG), a Cambridge, Mass.-based leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, raised more than $26m in Series A-1 financing. The round, which brought total funding... |
| 09.09.2019 | Platelet BioGenesis Raises $26 Million in Series A-1 Financing | CAMBRIDGE, Mass.,--(BUSINESS WIRE)--Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+) and platelet-based therapeutics, announced today that it has raised more than $26 million in Series A-1 ... |
| 12.06.2017 | Qiming US Healthcare Fund leads $10m Series A in Platelet BioGenesis | Premium Qiming US Healthcare Fund, a new US healthcare vehicle launched by China’s Qiming Venture Partners, has led a $10 million Series A financing round in Platelet BioGenesis, a Boston-based pre-clinical stage biotech company. Continue r... |
| 11.06.2017 | Platelet Biogenesis Raises $10M Series A | Platelet BioGenesis, a biotech startup developing a process to produce life-saving human platelets from stem cells for therapeutic applications, announced it has successfully raised $10 million in Series A financing. The round was led by Qi... |
| 09.06.2017 | Term Sheet — Friday, June 9 | NEW MONEY Good morning. A pair of Friday fundraising scoops for you… Paid Content Securing the enterprise without boundaries From ExtraHop Fortune first reported that Houzz was raising a large new round of funding in April. At the time, the... |
| 09.06.2017 | Platelet BioGenesis Raises $10M in Series A Funding | Platelet BioGenesis, a Boston, MA-based biotech startup developing a process to produce life-saving human platelets from stem cells for therapeutic applications, raised $10m in Series A financing. The round was led by Qiming U.S. Healthcare... |
| 08.06.2017 | Harvard University spinout raises $10M to advance platelet bioreactor technology | The new financing will support preclinical studies for Platelet BioGenesis’ stem cell-based bioreactors. The company hopes to begin clinical trials in around three years. By removing human donations from the platelet equation, Platelet Biog... |
| 21.04.2014 | Biochip mimics how the body produces platelets so they could be made in a lab | At least 1.5 million platelet transfusions are done in the U.S. each year, often to prevent hemorrhaging in people undergoing chemotherapy for hematologic cancers. They’re also sometimes used in trauma and general surgeries. The problem is ... |
| - | Harvard University spinout raises $10M to advance platelet bioreactor technology | Platelet BioGenesis’ bioreactor Boston-based Platelet BioGenesis has received $10 million in Series A financing to move their platelet manufacturing technology forward. The financing round for the Harvard University spinout was led by Qimin... |
| - | Biochip mimics how the body produces platelets so they could be made in a lab | When you hear about blood shortages, that doesn’t just mean there’s a shortage of donated red blood cells. It could also mean platelets, a blood component that Sven Karlsson described as Band-Aids of the bloodstream, because they’re necessa... |